Idiopathic Guttate Hypomelanosis Clinical Presentation

1. Ploysangam T, Dee-Ananlap S, Suvanprakorn P. Treatment of idiopathic guttate hypomelanosis with liquid nitrogen: light and electron microscopic studies. J Am Acad Dermatol. 1990 Oct. 23(4 Pt 1):681-4. [QxMD MEDLINE Link].

2. Ortonne JP, Perrot H. Idiopathic guttate hypomelanosis. Ultrastructural study. Arch Dermatol. 1980 Jun. 116(6):664-8. [QxMD MEDLINE Link].

3. Wallace ML, Grichnik JM, Prieto VG, Shea CR. Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol. 1998 Aug. 25(7):375-9. [QxMD MEDLINE Link].

4. Hamada T, Saito T, Sugai T, Morita Y. "Incontinentia pigmenti achromians (Ito)". Arch Dermatol. 1967 Dec. 96 (6):673-6. [QxMD MEDLINE Link].

5. Brown F, Crane JS. Idiopathic Guttate Hypomelanosis. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].

6. Arbache S, Michalany NS, de Almeida HL Jr, Hirata SH. Unveiling idiopathic guttate hypomelanosis: pathology, immunohistochemistry, and ultrastructural study. Int J Dermatol. 2022 Feb 3. [QxMD MEDLINE Link].

7. Kaya TI, Yazici AC, Tursen U, Ikizoglu G. Idiopathic guttate hypomelanosis: idiopathic or ultraviolet induced?. Photodermatol Photoimmunol Photomed. 2005 Oct. 21(5):270-1. [QxMD MEDLINE Link].

8. Errichetti E, Stinco G. Dermoscopy of idiopathic guttate hypomelanosis. J Dermatol. 2015 Jul 27. [QxMD MEDLINE Link].

9. Ankad BS, Beergouder SL. Dermoscopic evaluation of idiopathic guttate hypomelanosis: A preliminary observation. Indian Dermatol Online J. 2015 May-Jun. 6 (3):164-7. [QxMD MEDLINE Link].

10. Joshi R. Skip areas of retained melanin: a clue to the histopathological diagnosis of idiopathic guttate hypomelanosis. Indian J Dermatol. 2014 Nov. 59 (6):571-4. [QxMD MEDLINE Link].

11. Falabella R, Escobar C, Giraldo N, et al. On the pathogenesis of idiopathic guttate hypomelanosis. J Am Acad Dermatol. 1987 Jan. 16(1 Pt 1):35-44. [QxMD MEDLINE Link].

12. Asawanonda P, Sutthipong T, Prejawai N. Pimecrolimus for idiopathic guttate hypomelanosis. J Drugs Dermatol. 2010 Mar. 9(3):238-9. [QxMD MEDLINE Link].

13. Kubba A, Batrani M, Taneja A, Jain V. Tumor of follicular infundibulum: an unsuspected cause of macular hypopigmentation. Indian J Dermatol Venereol Leprol. 2014 Mar-Apr. 80 (2):141-4. [QxMD MEDLINE Link].

14. Pagnoni A, Kligman AM, Sadiq I, Stoudemayer T. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin. Acta Derm Venereol. 1999 Jul. 79(4):305-10. [QxMD MEDLINE Link].

15. Rerknimitr P, Disphanurat W, Achariyakul M. Topical tacrolimus significantly promotes repigmentation in idiopathic guttate hypomelanosis: a double-blind, randomized, placebo-controlled study. J Eur Acad Dermatol Venereol. 2013 Apr. 27(4):460-4. [QxMD MEDLINE Link].

16. Laosakul K, Juntongjin P. Efficacy of tip cryotherapy in the treatment of idiopathic guttate hypomelanosis (IGH): a randomized, controlled, evaluator-blinded study. J Dermatolog Treat. 2017 May. 28 (3):271-275. [QxMD MEDLINE Link].

17. Shin J, Kim M, Park SH, Oh SH. The effect of fractional carbon dioxide lasers on idiopathic guttate hypomelanosis: a preliminary study. J Eur Acad Dermatol Venereol. 2013 Feb. 27(2):e243-6. [QxMD MEDLINE Link].

18. Goldust M, Mohebbipour A, Mirmohammadi R. Treatment of idiopathic guttate hypomelanosis with fractional carbon dioxide lasers. J Cosmet Laser Ther. 2013 May 8. [QxMD MEDLINE Link].

19. Rerknimitr P, Chitvanich S, Pongprutthipan M, Panchaprateep R, Asawanonda P. Non-ablative fractional photothermolysis in treatment of idiopathic guttate hypomelanosis. J Eur Acad Dermatol Venereol. 2014 Oct 10. [QxMD MEDLINE Link].

20. Gordon JR, Reed KE, Sebastian KR, Ahmed AM. Excimer Light Treatment for Idiopathic Guttate Hypomelanosis: A Pilot Study. Dermatol Surg. 2017 Apr. 43 (4):553-557. [QxMD MEDLINE Link].

21. Kreeshan FC, Madan V. Idiopathic Guttate Hypomelanosis Treated with 308-nm Excimer Light and Topical Bimatoprost. J Cutan Aesthet Surg. 2021 Jan-Mar. 14 (1):115-117. [QxMD MEDLINE Link]. [Full Text].

22. Ravikiran SP, Sacchidanand S, Leelavathy B. Therapeutic wounding - 88% phenol in idiopathic guttate hypomelanosis. Indian Dermatol Online J. 2014 Jan. 5 (1):14-8. [QxMD MEDLINE Link].

23. Searle T, Al-Niaimi F, Ali FR. 5-Fluorouracil in Dermatology: The Diverse Uses Beyond Malignant and Premalignant Skin Disease. Dermatol Surg. 2021 Mar 1. 47 (3):e66-e70. [QxMD MEDLINE Link].

24. Rambhia SH, Rambhia KD. Treatment of idiopathic guttate hypomelanosis with 5-fluorouracil tattooing using a handheld needle. JAAD Int. 2020 Dec. 1 (2):200-201. [QxMD MEDLINE Link].

25. Arbache S, Roth D, Steiner D, et al. Activation of melanocytes in idiopathic guttate hypomelanosis after 5-fluorouracil infusion using a tattoo machine: Preliminary analysis of a randomized, split-body, single blinded, placebo controlled clinical trial. J Am Acad Dermatol. 2018 Jan. 78 (1):212-215. [QxMD MEDLINE Link]. [Full Text].

26. Shin MK, Jeong KH, Oh IH, Choe BK, Lee MH. Clinical features of idiopathic guttate hypomelanosis in 646 subjects and association with other aspects of photoaging. Int J Dermatol. 2011 Jul. 50(7):798-805. [QxMD MEDLINE Link].

Christopher R Gorman, MD Dermatologist, Central Virginia VA Health Care System

Christopher R Gorman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, Richmond Academy of Medicine, Virginia Dermatology Society

Disclosure: Nothing to disclose.

Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA

Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society

Disclosure: Nothing to disclose.

William D James, MD Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology, Society for Investigative Dermatology

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD<br/>Served as a speaker for various universities, dermatology societies, and dermatology departments.

Daniel Mark Siegel, MD, MS Clinical Professor of Dermatology, Department of Dermatology, State University of New York Downstate Medical Center

Daniel Mark Siegel, MD, MS is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Surgery, American Association for Physician Leadership, American Society for Dermatologic Surgery, American Society for MOHS Surgery, International Society for Dermatologic Surgery

Disclosure: Nothing to disclose.

Acknowledgments

Medscape Drugs & Diseases wishes to recognize Stephen W White, MD† for his original contributions to this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article